NEW YORK--(BUSINESS WIRE)--Cartesian Growth Corporation (“Cartesian”) (NASDAQ: GLBL), a publicly traded special purpose acquisition company, today announced the filing with the U.S. Securities and ...
About Cartesian Therapeutics Cartesian Therapeutics is a clinical ... in the “Risk Factors” section of the Company’s most recent Annual Report on Form 10-K and subsequently filed Quarterly Reports on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback